93 related articles for article (PubMed ID: 8090331)
41. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover.
Fassbender WJ; Ruf T; Kaiser HE; Stracke H
In Vivo; 2000; 14(5):619-24. PubMed ID: 11125546
[TBL] [Abstract][Full Text] [Related]
42. Circulating biochemical markers of bone remodeling in uremic patients.
Ureña P; De Vernejoul MC
Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
[TBL] [Abstract][Full Text] [Related]
43. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
44. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
45. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
46. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.
Dobnig H; Sipos A; Jiang Y; Fahrleitner-Pammer A; Ste-Marie LG; Gallagher JC; Pavo I; Wang J; Eriksen EF
J Clin Endocrinol Metab; 2005 Jul; 90(7):3970-7. PubMed ID: 15840739
[TBL] [Abstract][Full Text] [Related]
47. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
[TBL] [Abstract][Full Text] [Related]
48. Dose-response relationships between energy availability and bone turnover in young exercising women.
Ihle R; Loucks AB
J Bone Miner Res; 2004 Aug; 19(8):1231-40. PubMed ID: 15231009
[TBL] [Abstract][Full Text] [Related]
49. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
Tähtelä R; Thölix E
Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
[TBL] [Abstract][Full Text] [Related]
50. [Bone metabolism markers in patients with Basedow-Graves disease].
Vámos A; Balázs C
Orv Hetil; 1997 Sep; 138(38):2403-5. PubMed ID: 9380378
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
52. Quantitative bone scanning in the diagnosis of aluminium osteomalacia.
Worth DP; Smye SW; Robinson PJ; Davison AM; Will EJ
Nephrol Dial Transplant; 1989; 4(8):721-4. PubMed ID: 2510081
[TBL] [Abstract][Full Text] [Related]
53. Bone alkaline phosphatase isoenzyme in renal osteodystrophy.
Jarava C; Armas JR; Salgueira M; Palma A
Nephrol Dial Transplant; 1996; 11 Suppl 3():43-6. PubMed ID: 8840311
[TBL] [Abstract][Full Text] [Related]
54. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.
Parfitt AM; Simon LS; Villanueva AR; Krane SM
J Bone Miner Res; 1987 Oct; 2(5):427-36. PubMed ID: 3455625
[TBL] [Abstract][Full Text] [Related]
55. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
Joffe P; Heaf JG; Jensen C
Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
[TBL] [Abstract][Full Text] [Related]
56. [Bone metabolism as assessed with selected markers of bone turnover as well as densitometry analysis in patients after successful kidney transplantation].
Giza D; Stompór T; Katra B; Sieradzki J; Sułowicz W
Przegl Lek; 2001; 58(11):979-84. PubMed ID: 11987839
[TBL] [Abstract][Full Text] [Related]
57. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
[TBL] [Abstract][Full Text] [Related]
58. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
Jarava C; Armas JR; Palma A
Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
[TBL] [Abstract][Full Text] [Related]
59. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus.
Bouillon R; Bex M; Van Herck E; Laureys J; Dooms L; Lesaffre E; Ravussin E
J Clin Endocrinol Metab; 1995 Apr; 80(4):1194-202. PubMed ID: 7714089
[TBL] [Abstract][Full Text] [Related]
60. Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients.
Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M
Nephron; 2001 Mar; 87(3):283-5. PubMed ID: 11287766
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
